Business Context and Reporting Period
Company: PRO-DEX, INC. (PDEX)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three and six months ended December 31, 2024 (Fiscal Year 2025 Q1 and YTD)
Business Overview: Pro-Dex designs, develops, and manufactures autoclavable, battery-powered, and electric surgical drivers and shavers for orthopedic, thoracic, and maxocranial facial markets. The company also manufactures rotary air motors and provides non-recurring engineering (NRE) services.
Key Financial Metrics
| Metric (in thousands) | 3 Months Ended Dec 31, 2024 | 6 Months Ended Dec 31, 2024 | 6 Months Ended Dec 31, 2023 |
|---|---|---|---|
| Net Sales | $16,793 | $31,686 | $24,526 |
| Gross Profit | $5,072 | $10,222 | $6,460 |
| Gross Margin | 30.2% | 32.3% | 26.3% |
| Operating Income | $2,692 | $5,705 | $2,609 |
| Net Income | $2,040 | $4,506 | $(115) |
| Diluted EPS | $0.61 | $1.33 | $(0.03) |
| Cash and Equivalents | $66 | $66 | $1,289 |
| Total Debt (Notes Payable) | $16,431 | $16,431 | $11,956 |
| Working Capital | $27,161 | $27,161 | $26,610 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 33% year-over-year (YoY) for the quarter and 29% YoY for the six-month period. Medical device product sales rose 37% (quarter) and 32% (six months), driven primarily by a 69% increase in orthopedic sales due to a new handpiece launch.
- Profitability: The company returned to profitability, reporting net income of $4.5 million for the six months ended Dec 31, 2024, compared to a net loss of $115,000 in the prior year period. Gross margin expanded by 6 percentage points YoY.
- Cash Flow: Operating cash flow turned negative, using $2.3 million for the six months ended Dec 31, 2024, compared to providing $1.1 million in the prior year. This was driven by significant increases in accounts receivable ($4.6 million) and inventory ($4.3 million) to support backlog.
- Debt Structure: Total notes payable increased to $16.4 million from $12.0 million. The company secured a new $5.0 million Term Loan C in July 2024 and extended the maturity of its revolving loan to December 2026.
Guidance, Outlook, and Risks
- Backlog: As of December 31, 2024, the company reported a backlog of approximately $48.1 million, with $36.3 million scheduled for delivery in fiscal 2025.
- Liquidity: While cash on hand is low ($66,000), management attributes this to a temporary $2.1 million delay in collections from its largest customer, which has since been received. The company maintains $3.5 million in available revolver capacity and $6.3 million in marketable equity investments.
- Internal Controls: Management disclosed a material weakness in internal controls over financial reporting related to the existence of inventory. Remediation efforts include hiring a warehouse manager and implementing new cycle count procedures.
- Customer Concentration: The company faces high concentration risk. One customer accounted for 80% of sales in the quarter and 79% for the six months ended Dec 31, 2024. This same customer represented 84% of accounts receivable.
- Related Party Transactions: The company holds significant investments in Air T, Inc. and Monogram Technologies, Inc., involving board members and the CEO.
Investor Verification Checklist
- Inventory Existence: Verify the remediation of the material weakness regarding inventory controls and the accuracy of the $19.6 million inventory balance.
- Customer Concentration: Assess the risk associated with the top customer representing 80% of revenue and 84% of receivables.
- Cash Conversion: Monitor the collection of the $18.5 million accounts receivable balance to ensure operating cash flow stabilizes.
- Debt Covenants: Confirm continued compliance with debt covenants given the increased leverage and interest rate exposure on the new Term Loan C.
- Investment Valuation: Review the $6.3 million investment portfolio, noting the unrealized gains and related-party nature of holdings in Air T and Monogram.